Holen Sie sich die Stockscreener-App
14.19
5.28%
0.64
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Financial Times
UBS Group Upgrades Beta Bionics (NASDAQ:BBNX) to "Strong-Buy" - MarketBeat
Beta Bionics (NASDAQ:BBNX) Trading Up 7.9%Here's What Happened - MarketBeat
Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Essex Investment Management Co. LLC Takes Position in Beta Bionics, Inc. $BBNX - MarketBeat
Beta Bionics (NASDAQ:BBNX) Shares Gap UpTime to Buy? - MarketBeat
Resistance Check: How liquid is Beta Bionics Inc stockSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target - marketscreener.com
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
UBS initiates coverage on Beta Bionics stock with Buy rating By Investing.com - Investing.com Nigeria
UBS initiates coverage on Beta Bionics stock with Buy rating - Investing.com
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Beh - GuruFocus
Faruqi & Faruqi Investigates Aquestive Therapeutics for Investor Losses - intellectia.ai
Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 58% - simplywall.st
Artificial Pancreas System Market is expected to reach US$ - openPR.com
Stifel Nicolaus Lowers Beta Bionics (NASDAQ:BBNX) Price Target to $25.00 - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc.BBNX - Chartmill
Beta Bionics receives FDA warning letter - MedTech Dive
TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter - Investing.com Australia
TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter By Investing.com - Investing.com South Africa
Beta Bionics stock holds steady as TD Cowen reiterates $17 price target By Investing.com - Investing.com South Africa
Beta Bionics stock holds steady as TD Cowen reiterates $17 price target - Investing.com Canada
Truist Financial Has Lowered Expectations for Beta Bionics (NASDAQ:BBNX) Stock Price - MarketBeat
Balanced Risk-Reward Amid FDA Warning Letter Keeps Beta Bionics at Hold - TipRanks
Truist Securities lowers Beta Bionics stock price target to $25 from $37 By Investing.com - Investing.com South Africa
Truist Securities lowers Beta Bionics stock price target to $25 from $37 - Investing.com Nigeria
Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating - marketscreener.com
Beta Bionics, Inc. (NASDAQ:BBNX) Short Interest Down 24.0% in January - MarketBeat
Beta Bionics Receives FDA Warning Letter, Begins Remediation - TipRanks
Beta Bionics Receives FDA Warning Letter - TradingView
FDA warning letter hits Beta Bionics (NASDAQ: BBNX) but Mint plan stands - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - PR Newswire
Aug Volume: Will Beta Bionics Inc stock benefit from M AEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall ... - Caledonian Record
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Shareholders to Connect - accessnewswire.com
Beta Bionics stock initiated with Hold rating at TD Cowen By Investing.com - Investing.com Nigeria
TD Cowen Initiates Coverage of Beta Bionics (BBNX) with Hold Recommendation - Nasdaq
Today's Analyst Rating: BBNX Receives 'Hold' Rating from TD Cowe - GuruFocus
Beyond The Numbers: 4 Analysts Discuss Beta Bionics Stock - Benzinga
Beta Bionics posts strong results in inaugural public company year - BioWorld MedTech
Beta Bionics stock initiated with Hold rating at TD Cowen - Investing.com
TD Cowen Initiates Beta Bionics at Hold WIth Price Target $17 - marketscreener.com
1.20%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):